Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study-Reference-Cited by-同舟云学术

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

Published:2014-12 Issue:13 Volume:15 Page:1513-1520
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Franz David Neal,Belousova Elena,Sparagana Steven,Bebin E Martina,Frost Michael,Kuperman Rachel,Witt Olaf,Kohrman Michael H,Flamini J Robert,Wu Joyce Y,Curatolo Paolo,de Vries Petrus J,Berkowitz Noah,Anak Oezlem,Niolat Julie,Jozwiak Sergiusz

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR Inhibition;Budde;Am J Kidney Dis,2012

2. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease;Astrinidis;Oncogene,2005

3. The pathogenesis and imaging of the tuberous sclerosis complex;Baskin;Pediatr Radiol,2008

4. Imaging characteristics and growth of subependymal giant cell astrocytomas;Clarke;Neurosurgical Focus,2006

5. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis;Nabbout;J Neurol Neurosurg Psychiatry,1999

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature;Journal of Medical Case Reports;2024-07-20

2. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?;Neuropathology and Applied Neurobiology;2024-04

3. SEGA‐like circumscribed astrocytoma in a non‐NF1 patient, harboring molecular profile of GBM. A case report;Neuropathology;2023-11-02

4. Toxic effects of sirolimus and everolimus on the development and behavior of zebrafish embryos;Biomedicine & Pharmacotherapy;2023-10

5. Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions;Journal of Nephrology;2023-09-28